Adjuvant Use of BMAs in Breast Cancer
Biomarkers for Adjuvant Systemic Therapy in Early Breast Cancer
Biomarkers to Guide Systemic Therapy for Metastatic Breast Cancer
Bone Modifying Agents in Metastatic Cancer
Breast Cancer Risk Reduction
Breast Cancer Survivorship
Disease Management for HER2+ Breast Cancer with Brain Metastases
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer
Endocrine Therapy in Early Stage Cancer
ER/PR Testing for Diagnosis
Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer
Active Surveillance for the Management of Localized Prostate Cancer
Adjuvant and Salvage Radiotherapy after Prostatectomy
Brachytherapy for Prostate Cancer
Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer
Use of Germ Cell Tumor Markers to Guide Treatment
Fatigue in Cancer Survivors
Head and Neck Cancer Survivorship Care
Click the image below to submit new evidence for review.
Contact Site Administrator for assistance.
A Guideline or Provisional Clinical Opinion (PCO) is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines or PCOs do not account for individual variation among patients and may not reflect the most recent evidence. The Guideline or PCO does not recommend any particular product or course of medical treatment. Use of a guideline or PCO is voluntary.
The content on the site is for personal use only. Requests for reuse should be directed to email@example.com.
Terms & Conditions apply for this site.
©2015 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide